About cookies on this site Our websites require some cookies to function properly (required). In addition, other cookies may be used with your consent to analyze site usage, improve the user experience and for advertising. For more information, please review your options. By visiting our website, you agree to our processing of information as described in IBM’sprivacy statement. To provide a smooth navigation, your cookie preferences will be shared across the IBM web domains listed here.
Andrew Norden
Andrew Norden, MD
MD, MPH, MBA, Deputy Chief Health Officer, IBM Watson Health
A Trusted Treatment Option from Watson: Why Concordance Studies Matter
Hearing diverse opinions from multiple oncologists is an important part of a patient’s journey, what’s often referred to as getting a second – or third – opinion. And cancer docs, too, frequently consult with one another to confirm a decision or provide a new idea. That’s understandable because cancer is a complex and sometimes elusive […]
Putting Watson to the Test for Cancer Care
As a practicing neuro-oncologist, I believe in a collaborative approach to cancer care – involving the patient, their family, caregivers and a variety of clinical specialists. The cancer journey is challenging in so many ways that “going it alone” just isn’t an option if your goal is the best possible outcome. And today, with the […]